DKSH Business Unit Healthcare has entered into a distribution and promotion agreement with Eli Lilly Export S.A. to sell, promote and distribute Lilly’s pharmaceutical portfolio in Hong Kong and Macau, building on the companies’ existing collaborations in Singapore and Vietnam.

• Agreement Scope: DKSH will manage the sale, promotion and distribution of Lilly’s current pharmaceutical portfolio in Hong Kong and Macau.
• Continuity: Existing patient support programmes, medical, scientific and educational engagement, and global standards for product quality, safety monitoring and pharmacovigilance will remain in place.
• Partnership Expansion: The agreement extends the companies’ existing collaboration in Singapore and Vietnam to Hong Kong and Macau.

This summary is based on a press release issued by DKSH Management Ltd.

Image for illustrative purposes only. Source: Canva.

About Ehub365

For Corporate Clients, ehub365 division delivers critical insights into the ASEAN medical sector, covering investments, new services, and practitioner news. 

A member of 365Asia. Our additional group services are Health365, 365Asia, 健康365, 365Sehat, and 365MEC.